Coverage Validation Survey for Lymphatic Filariasis Treatment in Itang Special District of Gambella Regional State of Ethiopia: A Cross-Sectional Study

References

• Collyer BS, Irvine MA, Hollingsworth TD, Bradley M, Anderson RM. Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA). PLoS Negl Trop Dis. 2020;14(10):e0008644. doi:10.1371/journal.pntd.000864433044958
   PubMed Web of Science ®Google Scholar
• Belete Mengistu KD, Kebede F, Martindale S, et al. The national program to eliminate lymphatic filariasis from Ethiopia. Ethiop Med J. 2017;55(Suppl 1):45–54.28878429
   PubMedGoogle Scholar
• Nutman TB, Kazura JW. Tropical Infectious Diseases. 3rd ed. 2011.
   Google Scholar
• Deribe K, Meribo K, Gebre T, et al. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012;5:240. doi:10.1186/1756-3305-5-24023095679
   PubMed Web of Science ®Google Scholar
• Shiferaw W, Kebede T, Graves PM, et al. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas. Trans R Soc Trop Med Hyg. 2012;106(2):117–127. doi:10.1016/j.trstmh.2011.10.00622154976
   PubMed Web of Science ®Google Scholar
• Federal Democratic Republic of Ethiopia Ministry of Health. Second edition of national neglected tropical diseases master plan 2015/16-2019/20 (2008–2012 EFY) Addis Ababa, Ethiopia. 2016.
   Google Scholar
• Simonsen PE, Pedersen EM, Rwegoshora RT, et al. Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission. PLoS Negl Trop Dis. 2010;4(6):e696. doi:10.1371/journal.pntd.000069620532226
   PubMed Web of Science ®Google Scholar
• Michael E, Malecela-Lazaro MN, Simonsen PE, et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis. 2004;4:223–234. doi:10.1016/S1473-3099(04)00973-915050941
   PubMed Web of Science ®Google Scholar
• Simonsen PE, Derua YA, Magesa SM, et al. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration. Parasit Vectors. 2014;7:507. doi:10.1186/s13071-014-0507-525387483
   PubMed Web of Science ®Google Scholar
• Bockarie MJ, Tisch DJ, Katsens W, et al. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med. 2002;347:1841–1848. doi:10.1056/NEJMoa02130912466508
   PubMed Web of Science ®Google Scholar
• Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2017.
   Google Scholar
• Garchitorena A, Raza-Fanomezanjanahary M, Mioramalala SA, et al. Toward elimination of lymphatic filariasis in southeastern Madagascar: successes and challenges for interrupting transmission. PLoS Negl Trop Dis. 2018;12(9):e0006780. doi:10.1371/journal.pntd.000678030222758
   PubMed Web of Science ®Google Scholar
• Dorkenoo MA, Bronzan R, Yehadji D, et al. Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010–2015. Parasit Vectors. 2018;11(1):244. doi:10.1186/s13071-018-2843-329661231
   PubMed Web of Science ®Google Scholar
• Biritwum NK, Frempong KK, Verver S, et al. Progress towards lymphatic filariasis elimination in Ghana from 2000–2016: analysis of microfilaria prevalence data from 430 communities. PLoS Negl Trop Dis. 2019;13(8):e0007115. doi:10.1371/journal.pntd.000711531398203
   PubMed Web of Science ®Google Scholar
• Budge PJ, Sognikin E, Akosa A, Mathieu EM, Deming M. Accuracy of coverage survey recall following an integrated mass drug administration for lymphatic filariasis, schistosomiasis, and soil-transmitted helminthiasis. PLoS Negl Trop Dis. 2016;10(1):e0004358. doi:10.1371/journal.pntd.000435826766287
   PubMed Web of Science ®Google Scholar
• Wamae N, Njenga SM, Kisingu WM, et al. Community-directed treatment of lymphatic filariasis in Kenya and its role in the national programs for elimination of lymphatic filariasis. Afr J Health Sci. 2006;13(1–2):69–79. doi:10.4314/ajhs.v13i1.3081917348745
   PubMedGoogle Scholar
• Jones C, Ngasalla B, Derua YA, et al. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets. Int J Infect Dis. 2017;61:38–43. doi:10.1016/j.ijid.2017.05.00928527817
   PubMed Web of Science ®Google Scholar
• Specht S, Suma TK, Pedrique B, Hoerauf A. Elimination of lymphatic filariasis in South East Asia. BMJ. 2019;364:198. doi:10.1136/bmj.k5198
   Web of Science ®Google Scholar
• Deardorff KV, Rubin Means A, A´sbjo¨rnsdo´ttir KH, Walson J. Strategies to improve treatment coverage in community-based public health programs: a systematic review of the literature. PLoS Negl Trop Dis. 2018;12(2):1–20. doi:10.1371/journal.pntd.0006211
   Web of Science ®Google Scholar
• Griswold E, Eigege A, Ityonzughul C, et al. Evaluation of treatment coverage and enhanced mass drug administration for onchocerciasis and lymphatic filariasis in five local government areas treating twice per year in Edo state, Nigeria. Am J Trop Med Hyg. 2018;99(2):396–403. doi:10.4269/ajtmh.17-100429943709
   PubMed Web of Science ®Google Scholar
• World health organization. Coverage surveys for preventive chemotherapy: guidelines for implementation. 2016.
   Google Scholar